Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 1,995 citing Grady: Hormone therapy to prevent disease and prolong life in postmenopausal women. (0.11 sec) 

Randomized trial of estrogen plus progestin for secondary prevention of coronary …

- ama-assn.org [PDF] 
S Hulley, D Grady, T Bush, C Furberg, D Herrington, B … - Jama, 1998 - Am Med Assoc
You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do to make
your experience on this site better. ... Add to CiteULike Add to Connotea Add to ...
Cited by 4431 - Related articles - BL Direct - All 15 versions

Risk factors for hip fracture in white women

- motionhealth.com [PDF] 
SR Cummings, MC Nevitt, WS Browner, K … - The New England …, 1995 - nejm.highwire.org
Results During the follow-up period, 192 women had first hip fractures not due to motor vehicle
accidents. In multivariable age-adjusted analyses, a maternal history of hip fracture doubled
the risk of hip fracture (relative risk, 2.0; 95 percent confidence interval, 1.4 to 2.9), and the ...
Cited by 2160 - Related articles - BL Direct - All 20 versions

Randomised trial of effect of alendronate on risk of fracture in women with existing …

- wisc.edu [PDF] 
DM Black, SR Cummings, DB Karpf, JA Cauley, DE … - The Lancet, 1996 - Elsevier
Women aged 55–81 with low femoral-neck BMD were enrolled in two study groups based on
presence or absence of an existing vertebral fracture. Results for women with at least one vertebral
fracture at baseline are reported here. 2027 women were randomly assigned placebo ...
Cited by 2064 - Related articles - BL Direct - All 16 versions

The protective effects of estrogen on the cardiovascular system


ME Mendelsohn, RH Karas - The New England journal of medicine, 1999 - nejm.highwire.org
The incidence of cardiovascular disease differs significantly between men and women, in part
because of differences in risk factors and hormones. 1 The incidence of atherosclerotic diseases
is low in premenopausal women, rises in postmenopausal women, and is reduced to ...
Cited by 1876 - Related articles - BL Direct - All 15 versions

Prevention of coronary heart disease in clinical practice: recommendations of the …


D Wood, G De Backer, O Faergeman, I Graham, G … - Atherosclerosis, 1998 - Elsevier
The Task Force has summarised the most important clinical issues on CHD prevention on which
there is good agreement in order to give cardiologists and physicians—in hospital, the office
and the community—and other health care professionals, the best possible advice to ...
Cited by 1292 - Related articles - BL Direct - All 15 versions

Effects of estrogen replacement on the progression of coronary-artery …

- vcu.edu [PDF] 
DM Herrington, DM Reboussin, KB Brosnihan … - New England Journal …, 2000 - content.nejm.org
Results Estrogen and estrogen plus medroxyprogesterone acetate produced significant reductions
in low-density lipoprotein cholesterol levels (9.4 percent and 16.5 percent, respectively) and
significant increases in high-density lipoprotein cholesterol levels (18.8 percent and 14.2 ...
Cited by 1193 - Related articles - BL Direct - All 12 versions

Postmenopausal estrogen and progestin use and the risk of cardiovascular …


F Grodstein, MJ Stampfer, JAE Manson, GA … - New England Journal …, 1996 - content.nejm.org
Methods We examined the relation between cardiovascular disease and postmenopausal hormone
therapy during up to 16 years of follow-up in 59,337 women from the Nurses' Health Study, who
were 30 to 55 years of age at base line. Information on hormone use was ascertained ...
Cited by 1174 - Related articles - BL Direct - All 15 versions

Postmenopausal hormone therapy and mortality


F Grodstein, MJ Stampfer, GA Colditz, WC … - New England Journal …, 1997 - content.nejm.org
Methods We examined the relation between the use of postmenopausal hormones and mortality
among participants in the Nurses' Health Study, who were 30 to 55 years of age at base line
in 1976. Data were collected by biennial questionnaires beginning in 1976 and ...
Cited by 1040 - Related articles - BL Direct - All 12 versions

Estrogen plus progestin and the risk of coronary heart disease

- wisc.edu [PDF] 
JAE Manson, J Hsia, KC Johnson, JE … - The New England …, 2003 - nejm.highwire.org
From the Division of Preventive Medicine, Brigham and Women's Hospital and Har- vard Medical
School, Boston (JEM); the Department of Medicine, George Washing- ton University,
Washington, DC (JH); the Department of Preventive Medicine, Uni- versity of Tennessee ...
Cited by 909 - Related articles - BL Direct - All 22 versions

Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the …

- oxfordjournals.org [PDF] 
B Fisher, JP Costantino, CK Redmond, ER … - JNCI Journal of the …, 1994 - jnci.oxfordjournals.org
Background: Tamoxifen is advantageous in treating all stages of breast cancer. However, studies
have suggested that incidence and severity of endometrial cancer increase in women treated
with tamoxifen. Purpose: We compared rates of endometrial and other cancers in ...
Cited by 781 - Related articles - BL Direct - All 8 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google